Canntab Therapeutics Limited announced that the company has entered into an affiliate agreement with OnPharm-United. All member pharmacies will have access to educational information on medical cannabis, Canntab's exclusive hard tablet medical products including cannabidiol (CBD) and tetrahydrocannabinol (THC) and all necessary tools to permit the pharmacists to refer patients to the company website to fulfill their prescriptions for medical cannabis.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
Apr. 15 | Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding | CI |
2023 | Canntab Therapeutics Limited Provide an Update on Product Delivery | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 142K | |
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
+0.09% | 1.65B | |
-7.89% | 1.68B | |
-12.97% | 1.53B | |
+33.40% | 1.38B |
- Stock Market
- Equities
- PILL Stock
- News Canntab Therapeutics Limited
- Canntab Therapeutics Limited Enters into Affiliate Agreement with Onpharm-United